Home > Healthcare > Medical Devices > Diagnostic Devices > Anatomic Pathology Market

Anatomic Pathology Market Size

Report ID: GMI12097
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Anatomic Pathology Market Size

The global anatomic pathology market size was valued at around USD 36.7 billion in 2023 and is estimated to grow at 7.8% CAGR from 2024 to 2032. Anatomic pathology is a branch of pathology that focuses on the diagnosis of disease based on the examination of surgical specimens, tissues, and organs. It involves the study of the structural and functional changes in tissues and organs caused by disease processes. Anatomic pathologists utilize techniques such as histopathology, cytopathology, and autopsy pathology to analyze specimens at the cellular level.

anatomic pathology market

To get key market trends

Download Free Sample

The rising prevalence of cancer and other target diseases worldwide is a key driver of market growth in anatomic pathology. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. This increasing global burden of disease has led to a heightened demand for precise diagnostic techniques, including histopathology and cytopathology, which are essential for accurate disease identification and management.

Anatomic Pathology Market Report Attributes
Report Attribute	Details
Base Year:	2023
Anatomic Pathology Market Size in 2023:	USD 36.7 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	7.8%
2024 – 2032 Value Projection:	USD 71.9 Billion
Historical Data for:	2021-2023
No. of Pages:	145
Tables, Charts & Figures:	266
Segments covered:	Product and Service, Application, End Use, and Region
Growth Drivers:	Rising incidence of cancer and other target diseases worldwide Growing adoption of biomarkers Increasing number of clinical trials pertaining to cancer drugs Increasing technological advancements of pathology equipment
Pitfalls & Challenges:	High cost of equipment Availability of refurbished anatomic pathology systems

Learn more about the key segments shaping this market

Download Free Sample

Moreover, the growing adoption of biomarkers, an increasing number of clinical trials for cancer drugs, and advancements in pathology equipment are driving the anatomic pathology market. The use of biomarkers enhances diagnostic accuracy, while clinical trials highlight the need for precise histopathological evaluations. Additionally, technological improvements, such as digital pathology, boost efficiency and accuracy in diagnoses, collectively supporting the growth of the anatomic pathology sector.

Authors: Mariam Faizullabhoyg, Gauri Wani

Frequently Asked Questions (FAQ) :

The global anatomic pathology industry was valued at approximately USD 36.7 billion in 2023 and is estimated to grow at a 7.8% CAGR from 2024 to 2032, driven by advancements in diagnostic techniques.

The consumables segment led the market with a revenue of USD 19.2 billion in 2023 and is expected to grow significantly due to the essential role of high-quality consumables in improving diagnostic accuracy.

U.S. anatomic pathology market recorded USD 13.6 billion in 2023, driven by the high prevalence of cancer and the need for effective diagnostic solutions.

Key players in the industry include Agilent Technologies, Becton, Dickinson and Company, Cardinal Health, Danaher Corporation, F. Hoffmann-La Roche, Merck, Thermo Fisher Scientific, Ampath Laboratories, Al Borg Medical Laboratories, and Biolab.